China Universal Asset Management Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1M Buy
72,203
+9,793
+16% +$3.35M 1.56% 15
2026
Q1
$22M Sell
62,410
-9,124
-13% -$3.25M 1.66% 12
2025
Q4
$23.4M Buy
71,534
+6,906
+11% +$2.19M 1.8% 9
2025
Q3
$18.2M Buy
64,628
+4,201
+7% +$1.22M 1.51% 10
2025
Q2
$16.9M Sell
60,427
-5,054
-8% -$1.43M 1.59% 11
2025
Q1
$20.4M Sell
65,481
-8,123
-11% -$2.4M 1.9% 9
2024
Q4
$19.2M Buy
73,604
+19,266
+35% +$5.72M 1.79% 10
2024
Q3
$17.5M Buy
54,338
+22,603
+71% +$7.39M 1.93% 10
2024
Q2
$9.92M Sell
31,735
-25,659
-45% -$7.54M 1.4% 17
2024
Q1
$16.3M Buy
57,394
+25,510
+80% +$7.46M 2.07% 6
2023
Q4
$9.18M Buy
31,884
+21,667
+212% +$5.9M 1.79% 8
2023
Q3
$2.75M Buy
10,217
+4,549
+80% +$1.14M 0.8% 35
2023
Q2
$1.26M Buy
5,668
+589
+12% +$137K 0.39% 68
2023
Q1
$1.23M Buy
5,079
+1,985
+64% +$487K 0.42% 64
2022
Q4
$813K Buy
3,094
+2
+0.1% +$536 0.33% 72
2022
Q3
$697K Buy
+3,092
New +$749K 0.29% 70

Other funds holding AMGN

China Universal Asset Management Company's AMGN Position: Q2 2026 in Review

China Universal Asset Management Company increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $3.35M and bringing the position to 72,203 shares worth $26.1M. The position accounts for 1.56% of the portfolio, ranked #15.

China Universal Asset Management Company first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • China Universal Asset Management Company held 72,203 shares of Amgen worth $26.1M as of Q2 2026.
  • China Universal Asset Management Company bought 9,793 Amgen shares in Q2 2026, an estimated $3.35M.
  • Amgen made up 1.56% of China Universal Asset Management Company's portfolio in Q2 2026, its #15 holding.
  • China Universal Asset Management Company first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.